Literature DB >> 19861898

Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR.

Isidro Machado1, Rosa Noguera, Antonio Pellin, Jose A Lopez-Guerrero, Marta Piqueras, Samuel Navarro, Antonio Llombart-Bosch.   

Abstract

AIMS: To compare the sensitivity and specificity of fluorescence in situ hybridization (FISH) with reverse transcription polymerase chain reaction (RT-PCR) in the diagnosis of Ewing sarcoma family of tumors (ESFTs) and other small round-cell tumors (SRCTs) in formalin-fixed paraffin-embedded tissue assembled in tissue microarrays (TMAs). The second objective is to confirm the value of molecular methods and immunohistochemical (IHC) assays, to perform a differential diagnosis between ESFTs and SRCTs with similar or overlapping morphology.
MATERIALS AND METHODS: A total of 560 cases were selected for the present study out the 806 cases collected from the PROgnosis and THerapeutic Targets in the Ewing's Family of TumorS project. Case selection bias included only the cases with enough material to enable the TMA construction, as FISH analysis and the majority of IHC studies were performed in TMAs. Histopathologic, IHC, and molecular assays were carried out.
RESULTS: Of the 560 total cases, 411 (73.4%) were considered informative (with results by FISH and/or RT-PCR assays). From the informative cases, 382 (92.9%) were diagnosed as ESFT, 23 cases (5.6%) as non-ESFT but with specific diagnosis for another established entity, and 6 cases (1.5%) as small round cell tumors not otherwise specified. Sensitivity and specificity for the FISH assays was 96.3% and 95.2%, respectively, whereas RT-PCR presented a sensitivity of 97.5% and specificity of 92.9%. In concordant cases, both methods showed a sensitivity and specificity of 99.2% and 100%, respectively. Twenty-nine cases (7.1%) initially interpreted at morphologic level as atypical ESFTs were finally reclassified, with the support of molecular methods and IHC, as either non-ESFT with another specific histologic type or as small round cell tumors not otherwise specified.
CONCLUSIONS: FISH and RT-PCR are ancillary techniques possessing high sensitivity in the diagnosis of ESFT; nevertheless, FISH is more specific than RT-PCR in the diagnosis of formalin-fixed paraffin-embedded tissue. Both methods in combination displayed the highest sensitivity and specificity. The combination of histopathologic, IHC, and molecular findings is the method of choice for the diagnosis of ESFT, as well as for the differential diagnosis with other SRCTs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861898     DOI: 10.1097/PDM.0b013e3181a06f66

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  25 in total

Review 1.  [Avoiding pitfalls in the diagnostics of bone neoplasms: importance of reference pathology].

Authors:  M Werner
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  The many faces of atypical Ewing's sarcoma. A true entity mimicking sarcomas, carcinomas and lymphomas.

Authors:  Isidro Machado; Rosa Noguera; Eduardo Alcaraz Mateos; Silvia Calabuig-Fariñas; F Ignacio Aranda López; Antonio Martínez; Samuel Navarro; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2010-12-23       Impact factor: 4.064

3.  Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support.

Authors:  Antonio Llombart-Bosch; Isidro Machado; Samuel Navarro; Franco Bertoni; Patrizia Bacchini; Marco Alberghini; Apollon Karzeladze; Nikita Savelov; Semyon Petrov; Isabel Alvarado-Cabrero; Doina Mihaila; Philippe Terrier; Jose Antonio Lopez-Guerrero; Piero Picci
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

4.  Epithelial marker expression does not rule out a diagnosis of Ewing's sarcoma family of tumours.

Authors:  Isidro Machado; Samuel Navarro; Jose A López-Guerrero; Marco Alberghini; Piero Picci; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2011-09-02       Impact factor: 4.064

5.  Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years.

Authors:  Gabriella Gamberi; Stefania Cocchi; Stefania Benini; Giovanna Magagnoli; Luca Morandi; Jennifer Kreshak; Marco Gambarotti; Piero Picci; Licciana Zanella; Marco Alberghini
Journal:  J Mol Diagn       Date:  2011-03-31       Impact factor: 5.568

6.  Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.

Authors:  Bharat Rekhi; Ulrich Vogel; Ranjan Basak; Sangeeta B Desai; Nirmala A Jambhekar
Journal:  Pathol Oncol Res       Date:  2013-11-30       Impact factor: 3.201

Review 7.  [Avoiding pitfalls in the diagnostics of bone neoplasms from pathologists point of view : Importance of reference pathology].

Authors:  M Werner
Journal:  Radiologe       Date:  2016-06       Impact factor: 0.635

8.  Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic Differentiation.

Authors:  Abhijit Chougule; Martin S Taylor; Valentina Nardi; Ivan Chebib; Gregory M Cote; Edwin Choy; G Petur Nielsen; Vikram Deshpande
Journal:  Am J Surg Pathol       Date:  2019-02       Impact factor: 6.394

9.  UK Guidelines for the Management of Bone Sarcomas.

Authors:  Robert Grimer; Nick Athanasou; Craig Gerrand; Ian Judson; Ian Lewis; Bruce Morland; David Peake; Beatrice Seddon; Jeremy Whelan
Journal:  Sarcoma       Date:  2010-12-29

10.  Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer: comparison between FISH and RT-PCR.

Authors:  A Fernández-Serra; L Rubio; A Calatrava; J Rubio-Briones; R Salgado; R Gil-Benso; B Espinet; Z García-Casado; J A López-Guerrero
Journal:  Biomed Res Int       Date:  2013-05-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.